Metrovacesa Balance Sheet Health
Financial Health criteria checks 4/6
Metrovacesa has a total shareholder equity of €1.6B and total debt of €435.0M, which brings its debt-to-equity ratio to 26.6%. Its total assets and total liabilities are €2.5B and €874.7M respectively. Metrovacesa's EBIT is €90.2M making its interest coverage ratio 3.9. It has cash and short-term investments of €163.1M.
Key information
26.6%
Debt to equity ratio
€434.96m
Debt
| Interest coverage ratio | 3.9x |
| Cash | €163.13m |
| Equity | €1.63b |
| Total liabilities | €874.73m |
| Total assets | €2.51b |
Recent financial health updates
We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt
May 01
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Nov 05These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively
Jul 05Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Dec 02Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?
Feb 16Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Oct 05Recent updates
Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?
Jul 17A Look At The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)
May 28We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt
May 01Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?
Mar 27A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)
Feb 12Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Nov 05These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively
Jul 05Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?
May 21Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)
Apr 19Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Dec 02Is It Too Late To Consider Buying Metrovacesa S.A. (BME:MVC)?
Sep 23Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)
May 19Metrovacesa's (BME:MVC) Strong Earnings Are Of Good Quality
Mar 05Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?
Feb 16Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Oct 05Is Metrovacesa S.A. (BME:MVC) Worth €6.7 Based On Its Intrinsic Value?
Jul 02Is Metrovacesa (BME:MVC) Using Too Much Debt?
May 06Is Metrovacesa S.A. (BME:MVC) A Strong Dividend Stock?
Apr 06Metrovacesa (BME:MVC) Share Prices Have Dropped 51% In The Last Three Years
Mar 15Loss-Making Metrovacesa S.A. (BME:MVC) Set To Breakeven
Feb 16When Should You Buy Metrovacesa S.A. (BME:MVC)?
Jan 26
A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)
Jan 05If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%
Dec 14Financial Position Analysis
Short Term Liabilities: MVC's short term assets (€2.1B) exceed its short term liabilities (€598.4M).
Long Term Liabilities: MVC's short term assets (€2.1B) exceed its long term liabilities (€276.4M).
Debt to Equity History and Analysis
Debt Level: MVC's net debt to equity ratio (16.6%) is considered satisfactory.
Reducing Debt: MVC's debt to equity ratio has increased from 5.1% to 26.6% over the past 5 years.
Debt Coverage: MVC's debt is not well covered by operating cash flow (12.5%).
Interest Coverage: MVC's interest payments on its debt are well covered by EBIT (3.9x coverage).